Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AXNX

Axonics Inc

Nov 30 • 04:00PM ET

55.99

Dollar change -1.02
Percentage change -1.79	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.25	Insider Own	1.02%	Shs Outstand	50.66M	Perf Week	-3.18%
Market Cap	2.84B	Forward P/E	162.17	EPS next Y	0.35	Insider Trans	-4.43%	Shs Float	50.15M	Perf Month	9.33%
Income	-12.00M	PEG	-	EPS next Q	0.06	Inst Own	102.78%	Short Float / Ratio	4.31% / 3.89	Perf Quarter	-2.29%
Sales	342.56M	P/S	8.28	EPS this Y	89.13%	Inst Trans	3.04%	Short Interest	2.16M	Perf Half Y	13.55%
Book/sh	12.05	P/B	4.65	EPS next Y	348.17%	ROA	-1.86%	Target Price	68.57	Perf Year	-13.40%
Cash/sh	6.80	P/C	8.23	EPS next 5Y	-	ROE	-2.07%	52W Range	47.59 - 71.99	Perf YTD	-10.46%
Dividend	-	P/FCF	-	EPS past 5Y	-14.51%	ROI	-1.96%	52W High	-22.23%	Beta	0.48
Dividend %	-	Quick Ratio	11.25	Sales past 5Y	625.42%	Gross Margin	71.72%	52W Low	17.65%	ATR	2.25
Employees	610	Current Ratio	13.36	Sales Q/Q	32.27%	Oper. Margin	-3.15%	RSI (14)	52.46	Volatility	3.57% 3.92%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	122.77%	Profit Margin	-3.50%	Rel Volume	1.67	Prev Close	57.01
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Oct 30 AMC	Payout	-	Avg Volume	555.17K	Price	55.99
Recom	1.29	SMA20	1.77%	SMA50	2.47%	SMA200	1.86%	Volume	910,811	Change	-1.79%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-19-23	Initiated	Robert W. Baird	Outperform	$69
Jul-13-23	Initiated	KeyBanc Capital Markets	Overweight	$70
May-23-23	Initiated	CL King	Buy	$75
Apr-14-23	Initiated	Mizuho	Buy	$75
Mar-24-23	Upgrade	Needham	Hold → Buy	$71
Oct-21-22	Initiated	RBC Capital Mkts	Outperform	$85
Oct-12-22	Initiated	Jefferies	Hold	$75
Oct-10-22	Downgrade	Needham	Buy → Hold
Apr-06-22	Initiated	Wolfe Research	Outperform	$69
Mar-02-22	Resumed	BofA Securities	Buy	$70
Jul-12-21	Initiated	Barclays	Overweight	$74
Jun-28-21	Reiterated	Needham	Buy	$72 → $78
Nov-05-20	Reiterated	Needham	Buy	$57 → $62
Oct-23-20	Initiated	Guggenheim	Buy	$77
Sep-02-20	Initiated	Robert W. Baird	Outperform	$52
Aug-07-20	Reiterated	Needham	Buy	$48 → $57
Jan-08-20	Initiated	SunTrust	Buy	$38
Nov-01-19	Initiated	Piper Jaffray	Overweight	$39
Oct-21-19	Initiated	Barclays	Overweight	$43
Sep-17-19	Initiated	SVB Leerink	Outperform	$45

Show Previous Ratings

Nov-20-23 09:55AM	Wall Street Analysts Believe Axonics (AXNX) Could Rally 25.1%: Here's is How to Trade (Zacks)
Nov-06-23 12:00PM	Revolutionizing Care: NeuroQure's Groundbreaking Path to Treating Genetic Intellectual Disabilities (GlobeNewswire)
Nov-01-23 06:00AM	Axonics to Participate in November Investor Conferences (Business Wire)
Oct-31-23 09:27AM	Axonics, Inc. (NASDAQ:AXNX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-30-23 05:55PM	Axonics Inc (AXNX) Reports 32% YoY Revenue Growth in Q3 2023 (GuruFocus.com)
05:40PM	Loading…
05:40PM	Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates (Zacks)
04:28PM	Axonics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Axonics Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-26-23 10:02AM	IRhythm Technologies (IRTC) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-23-23 10:00AM	Axonics Modulation Technologies (AXNX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-16-23 10:23AM	Wayfair upgraded, JD.com downgraded: Wall Street's top analyst calls (The Fly)
Oct-14-23 01:15PM	13 Stocks to Buy with Exponential Growth (Insider Monkey)
Oct-11-23 11:42AM	Unveiling Axonics (AXNX)'s True Worth: A Comprehensive Guide to Its Market Value (GuruFocus.com) -6.07%
Oct-02-23 06:00AM	Axonics to Report Third Quarter 2023 Financial Results on October 30 (Business Wire)
Sep-22-23 11:47AM	Unveiling Axonics (AXNX)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
11:47AM	Loading…
Sep-11-23 11:47AM	Axonics (AXNX): A Significantly Undervalued Gem in the Medical Technology Sector? (GuruFocus.com) +5.44%
Aug-25-23 06:00AM	Axonics to Participate in September Investor Conferences (Business Wire)
Aug-21-23 06:00AM	Axonics Announces CFO Retirement and Appoints Successor (Business Wire)
Jul-28-23 12:46PM	Why Shares of Axonics Rose Friday (Motley Fool) +14.81%
Jul-27-23 05:25PM	Axonics Modulation Technologies (AXNX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:18PM	Axonics: Q2 Earnings Snapshot (AP Finance)
04:01PM	Axonics Reports Second Quarter 2023 Financial Results (Business Wire)
Jun-29-23 06:00AM	Axonics to Report Second Quarter 2023 Financial Results on July 27 (Business Wire)
May-31-23 10:27AM	Even though Axonics (NASDAQ:AXNX) has lost US$173m market cap in last 7 days, shareholders are still up 28% over 3 years (Simply Wall St.)
May-25-23 09:28AM	Were Going Up: Billionaire Steve Cohen Loads Up on These 2 Strong Buy Stocks Heres Why You Should Follow (TipRanks)
May-16-23 02:45AM	What Makes Axonics (AXNX) Unique? (Insider Monkey)
May-08-23 09:06AM	A Look At The Intrinsic Value Of Axonics, Inc. (NASDAQ:AXNX) (Simply Wall St.)
May-01-23 05:15PM	Axonics Modulation Technologies (AXNX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Axonics: Q1 Earnings Snapshot (AP Finance)
04:01PM	Axonics Reports First Quarter 2023 Financial Results (Business Wire)
06:00AM	Loading…
Apr-25-23 06:00AM	Axonics to Participate in Upcoming Investor Conferences (Business Wire)
Apr-24-23 06:00AM	Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation (Business Wire)
Apr-17-23 03:54PM	Investors Interested In Axonics, Inc.'s (NASDAQ:AXNX) Revenues (Simply Wall St.)
Apr-10-23 06:00AM	Axonics to Report First Quarter 2023 Financial Results on May 1 (Business Wire)
Mar-29-23 06:00AM	Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas (Business Wire)
Mar-07-23 06:00AM	Axonics to Participate in the SUFU 2023 Winter Meeting (Business Wire)
Mar-04-23 07:39AM	Axonics Full Year 2022 Earnings: EPS Beats Expectations (Simply Wall St.)
Mar-01-23 05:25PM	Axonics Modulation Technologies (AXNX) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
04:01PM	Axonics Reports Fourth Quarter and Fiscal Year 2022 Financial Results (Business Wire)
Feb-25-23 02:14PM	12 Most Promising Medical Stocks According to Analysts (Insider Monkey)
Feb-22-23 10:00AM	Axonics Modulation Technologies (AXNX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-08-23 04:30PM	Axonics to Report Fourth Quarter 2022 Financial Results on March 1 (Business Wire)
Jan-31-23 06:00AM	Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System (Business Wire)
Jan-19-23 06:43AM	Daily Vickers Top Buyers & Sellers for 01/19/2023 (Argus Research) -6.20%
Jan-12-23 09:19AM	Axonics (AXNX) Soars 10.6%: Is Further Upside Left in the Stock? (Zacks)
07:21AM	When Will Axonics, Inc. (NASDAQ:AXNX) Breakeven? (Simply Wall St.)
Jan-11-23 06:00AM	Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance (Business Wire) +10.60%
Dec-23-22 12:58PM	3 Hot Stocks Going Into the Holiday Weekend (Zacks)
Dec-22-22 09:03AM	The 6.9% return this week takes Axonics' (NASDAQ:AXNX) shareholders three-year gains to 136% (Simply Wall St.)
Dec-21-22 06:00AM	Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-19-22 09:40AM	Is Axonics (AXNX) Outperforming Other Medical Stocks This Year? (Zacks)
Dec-13-22 12:40PM	Should You Invest in Axonics (AXNX)? (Insider Monkey)
06:00AM	Axonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System (Business Wire)
Dec-02-22 09:40AM	Is GlycoMimetics (GLYC) Outperforming Other Medical Stocks This Year? (Zacks)
07:10AM	2 Fast-Growing Healthcare Stocks to Buy and Hold (Motley Fool)
Nov-18-22 06:00AM	Axonics® to Participate in the Piper Sandler Healthcare Conference (Business Wire)
Nov-16-22 11:06AM	Axonics® Ranked No. 4 on the 2022 Deloitte Technology Fast 500 List of the Fastest Growing Companies in North America (Business Wire)
09:40AM	Are Medical Stocks Lagging Axonics (AXNX) This Year? (Zacks)
Nov-07-22 12:52PM	Are Investors Undervaluing Axonics, Inc. (NASDAQ:AXNX) By 36%? (Simply Wall St.)
Nov-01-22 12:35PM	Why Axonics (AXNX) Surged in the Third Quarter? (Insider Monkey) -6.81%
Oct-31-22 05:15PM	Axonics Modulation Technologies (AXNX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Axonics® Reports Third Quarter 2022 Financial Results (Business Wire)
09:40AM	Is AMN Healthcare Services (AMN) Outperforming Other Medical Stocks This Year? (Zacks)
Oct-24-22 10:00AM	Axonics Modulation Technologies (AXNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-13-22 09:40AM	Is Axonics (AXNX) Outperforming Other Medical Stocks This Year? (Zacks)
Oct-09-22 10:20AM	We Think Axonics (NASDAQ:AXNX) Can Easily Afford To Drive Business Growth (Simply Wall St.)
Sep-26-22 09:40AM	Has Axonics (AXNX) Outpaced Other Medical Stocks This Year? (Zacks)
Sep-12-22 09:15AM	Axonics Inc. (AXNX) Soars to 52-Week High, Time to Cash Out? (Zacks)
Sep-08-22 06:00AM	Axonics® Announces First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation System (Business Wire) +5.02%
Sep-07-22 09:40AM	Has Assertio (ASRT) Outpaced Other Medical Stocks This Year? (Zacks)
Aug-22-22 09:40AM	Are Medical Stocks Lagging Axonics (AXNX) This Year? (Zacks)
Aug-18-22 06:00AM	Axonics® to Participate in September Investor Conferences (Business Wire)
Aug-17-22 06:00AM	Axonics® Expands Sacral Neuromodulation Intellectual Property Portfolio (Business Wire)
Aug-08-22 12:00PM	Here's Why Axonics Modulation Technologies (AXNX) is a Great Momentum Stock to Buy (Zacks)
Aug-05-22 04:34PM	Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters Option to Purchase Additional Stock (Business Wire)
Aug-04-22 09:40AM	Is Axonics (AXNX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Aug-02-22 11:13PM	Axonics® Announces Pricing of Public Offering of Common Stock (Business Wire) +6.78%
04:11PM	Axonics® Announces Proposed Public Offering of Common Stock (Business Wire)
Aug-01-22 05:15PM	Axonics Modulation Technologies (AXNX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Axonics® Reports Second Quarter 2022 Financial Results (Business Wire)
Jul-19-22 09:40AM	Is Axonics (AXNX) Outperforming Other Medical Stocks This Year? (Zacks)
Jul-15-22 07:24AM	Axonics' (NASDAQ:AXNX) investors will be pleased with their decent 62% return over the last three years (Simply Wall St.)
Jul-11-22 06:00AM	Axonics® to Report Second Quarter 2022 Financial Results on August 1 (Business Wire)
Jun-24-22 09:40AM	Has Axonics (AXNX) Outpaced Other Medical Stocks This Year? (Zacks)
Jun-15-22 08:18AM	Baron Funds: We are Excited About Axonics (AXNX)s Future Growth Prospects (Insider Monkey)
May-31-22 06:00AM	Axonics® Files PMA Supplement with FDA for Fourth Generation Rechargeable Neurostimulator (Business Wire)
May-05-22 05:45PM	Axonics Modulation Technologies (AXNX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -9.03%
04:01PM	Axonics® Reports First Quarter 2022 Financial Results (Business Wire)
May-02-22 08:19AM	Axonics (NASDAQ:AXNX) Is In A Strong Position To Grow Its Business (Simply Wall St.) +11.31%
Apr-28-22 03:02PM	Analysts Estimate Axonics Modulation Technologies (AXNX) to Report a Decline in Earnings: What to Look Out for (Zacks) -5.04%
Apr-26-22 06:00AM	Axonics® to Participate in BofA Securities 2022 Healthcare Conference (Business Wire)
Apr-19-22 06:00AM	Axonics® Announces Comprehensive Launch of the Axonics F15 Recharge-Free Sacral Neuromodulation System (Business Wire)
Apr-14-22 04:01PM	Axonics® to Report First Quarter 2022 Financial Results on May 5 (Business Wire)
Apr-04-22 06:00AM	Axonics® Launches Direct to Consumer Television Advertising Campaign (Business Wire)
Mar-23-22 09:28AM	iRhythm Technologies (IRTC) Soars 4.3%: Is Further Upside Left in the Stock? (Zacks)
Mar-07-22 04:01PM	Axonics® Receives FDA Approval for Recharge-Free Sacral Neuromodulation System (Business Wire)
Feb-24-22 06:20PM	Axonics Modulation Technologies (AXNX) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +10.14%
04:01PM	Axonics® Reports Fourth Quarter and Fiscal Year 2021 Financial Results (Business Wire)
Feb-23-22 05:25PM	IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Feb-17-22 03:02PM	Earnings Preview: Axonics Modulation Technologies (AXNX) Q4 Earnings Expected to Decline (Zacks) -7.48%

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dearen Danny L.	President & CFO	Sep 29	Option Exercise	0.00	11,250	0	31,452	Oct 03 07:37 PM
Dearen Danny L.	President & CFO	Sep 29	Sale	56.87	7,675	436,490	23,777	Oct 03 07:37 PM
Ford Alfred J Jr	Chief Commercial Officer	Aug 15	Sale	62.34	14,769	920,671	34,565	Aug 17 07:47 PM
Ford Alfred J Jr	Chief Commercial Officer	Jul 28	Sale	62.01	1,500	93,021	49,334	Aug 01 08:01 PM
Dearen Danny L.	President & CFO	May 26	Sale	49.46	7,999	395,646	9,202	May 31 08:01 PM
Dearen Danny L.	President & CFO	Apr 21	Option Exercise	14.19	13,208	187,422	37,201	Apr 25 08:06 PM
Dearen Danny L.	President & CFO	Apr 21	Sale	60.21	20,000	1,204,137	17,201	Apr 25 08:06 PM
Dearen Danny L.	President & CFO	Apr 20	Option Exercise	14.19	2,001	28,394	25,994	Apr 24 08:35 PM
Dearen Danny L.	President & CFO	Apr 20	Sale	60.01	2,001	120,073	23,993	Apr 24 08:35 PM
Dearen Danny L.	President & CFO	Mar 31	Option Exercise	16.00	15,000	240,031	38,993	Apr 04 08:24 PM
Dearen Danny L.	President & CFO	Mar 31	Sale	55.27	15,000	829,103	23,993	Apr 04 08:24 PM
Sama Rinda	Chief Operating Officer	Feb 21	Sale	56.27	19,929	1,121,415	55,854	Feb 23 08:19 PM
Sama Rinda	Chief Operating Officer	Feb 21	Sale	56.53	3,392	191,750	608	Feb 23 08:19 PM
COHEN RAYMOND W	Chief Executive Officer	Feb 01	Sale	60.93	8,117	494,578	160,596	Feb 02 08:06 PM
Sama Rinda	Chief Operating Officer	Feb 01	Sale	60.93	5,075	309,225	75,783	Feb 02 08:07 PM
Woock John	EVP, Chief Mktg/Strtgy Officer	Feb 01	Sale	60.93	3,979	242,445	65,302	Feb 02 08:06 PM
Ford Alfred J Jr	Chief Commercial Officer	Feb 01	Sale	60.93	3,705	225,750	50,834	Feb 02 08:07 PM
Dearen Danny L.	President & CFO	Feb 01	Sale	60.93	3,246	197,782	23,993	Feb 02 08:06 PM
Noblett Karen	Chief Medical Officer	Feb 01	Sale	60.93	931	56,727	42,215	Feb 02 08:06 PM
Dearen Danny L.	President & CFO	Jan 31	Option Exercise	0.00	25,250	0	37,750	Feb 02 08:06 PM
Ford Alfred J Jr	Chief Commercial Officer	Jan 31	Option Exercise	0.00	16,500	0	60,773	Feb 02 08:07 PM
Sama Rinda	Chief Operating Officer	Jan 31	Option Exercise	0.00	30,875	0	94,283	Feb 02 08:07 PM
COHEN RAYMOND W	Chief Executive Officer	Jan 31	Option Exercise	0.00	61,968	0	191,617	Feb 02 08:06 PM
Woock John	EVP, Chief Mktg/Strtgy Officer	Jan 31	Option Exercise	0.00	22,125	0	76,851	Feb 02 08:06 PM
Noblett Karen	Chief Medical Officer	Jan 31	Option Exercise	0.00	10,250	0	46,849	Feb 02 08:06 PM
COHEN RAYMOND W	Chief Executive Officer	Jan 31	Sale	61.15	22,904	1,400,595	168,713	Feb 02 08:06 PM
Sama Rinda	Chief Operating Officer	Jan 31	Sale	61.15	13,425	820,932	80,858	Feb 02 08:07 PM
Dearen Danny L.	President & CFO	Jan 31	Sale	61.16	10,511	642,822	27,239	Feb 02 08:06 PM
Woock John	EVP, Chief Mktg/Strtgy Officer	Jan 31	Sale	61.14	7,570	462,854	69,281	Feb 02 08:06 PM
Ford Alfred J Jr	Chief Commercial Officer	Jan 31	Sale	61.15	6,234	381,235	54,539	Feb 02 08:07 PM
Noblett Karen	Chief Medical Officer	Jan 31	Sale	61.15	3,703	226,437	43,146	Feb 02 08:06 PM
Woock John	EVP, Chief Mktg/Strtgy Officer	Jan 17	Option Exercise	17.48	30,215	528,050	60,976	Jan 19 08:07 PM
Woock John	EVP, Chief Mktg/Strtgy Officer	Jan 17	Sale	67.34	30,215	2,034,531	45,976	Jan 19 08:07 PM
Ford Alfred J Jr	Chief Commercial Officer	Jan 13	Option Exercise	13.52	36,015	486,817	72,788	Jan 18 08:03 PM
COHEN RAYMOND W	Chief Executive Officer	Jan 13	Sale	65.94	40,736	2,686,001	108,899	Jan 18 08:04 PM
Ford Alfred J Jr	Chief Commercial Officer	Jan 13	Sale	66.40	36,015	2,391,415	36,773	Jan 18 08:03 PM
Lopez Esteban	Director	Dec 13	Sale	67.42	2,000	134,840	3,600	Dec 15 08:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AXNX

Axonics Inc

Upgrade your FINVIZ experience